Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.39 |
| ▸ | CA1 | P00915 | 3/20 | 0.38 |
| ▸ | MMP1 | P03956 | 2/20 | 0.38 |
| ▸ | MMP2 | P08253 | 2/20 | 0.38 |
| ▸ | MMP9 | P14780 | 2/20 | 0.38 |
| ▸ | MMP8 | P22894 | 2/20 | 0.38 |
| ▸ | MMP13 | P45452 | 2/20 | 0.38 |
| ▸ | F2 | P00734 | 2/20 | 0.33 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.33 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.33 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13684270 | 0.96 | CA2 (0.43) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL11788241 | 0.96 | CA2 (0.43) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL103406 | 0.92 | CA2 (0.33) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL73684 | 0.90 | CA2 (0.52) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL6898759 | 0.87 | CA2 (0.50) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL584864 | 0.87 | CA2 (0.56) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL585308 | 0.87 | CA2 (0.56) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL7660482 | 0.87 | CA2 (0.56) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL302264 | 0.87 | CA2 (0.56) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL585171 | 0.87 | CA2 (0.56) | CA2CA1MMP1MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9861977-B2 | Multi-acid polymers and methods of making the same | NISSAN NORTH AMERICA, INC. (US) | 2018-01-09 | — | — | US | claimed |
| US-20170274368-A1 | MULTI-ACID POLYMERS AND METHODS OF MAKING THE SAME | NISSAN MOTOR CO., LTD. (JP) | 2017-09-28 | — | — | US | claimed |
| US-12034193-B2 | Fluorinated copolymer and compositions and articles including the same | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2024-07-09 | — | — | US | disclosed |
| US-20240204227-A1 | Fluoropolymer Comprising Pendent Groups with Ionic Bis(Sulfonyl)Imide Moiety and Perfluoroether Terminal Group | UNITED STATES DEPARTMENT OF ENERGY | 2024-06-20 | — | — | US | disclosed |
| WO-2023162574-A1 | COMPOSITION, FILM, OPTICAL FILTER, SOLID-STATE IMAGING ELEMENT, IMAGE DISPLAY DEVICE, INFRARED SENSOR, CAMERA MODULE, AND COMPOUND | 富士フイルム株式会社 | 2023-08-31 | — | — | WO | disclosed |
| EP-3353221-B1 | METHOD OF MAKING A COPOLYMER OF TETRAFLUOROETHYLENE HAVING SULFONYL PENDANT GROUPS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-06-07 | — | — | EP | disclosed |
| WO-2023057926-A1 | COMPOSITE INCLUDING FLUORINATED POLYMER AND LITHIUM FLUORIDE NANOPARTICLES AND ARTICLES INCLUDING THE SAME | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-04-13 | — | — | WO | disclosed |
| US-20230090482-A1 | COMPOSITE INCLUDING FLUORINATED POLYMER AND SALT NANOPARTICLES AND ARTICLES INCLUDING THE SAME | 3M INNOVATIVE PROPERTIES COMPANY | 2023-03-23 | — | — | US | disclosed |
| US-20230056130-A1 | Fluorinated Copolymer and Compositions and Articles Including the Same | 3M INNOVATIVE PROPERTIES COMPANY | 2023-02-23 | — | — | US | disclosed |
| EP-4133542-A1 | COMPOSITE INCLUDING FLUORINATED POLYMER AND SALT NANOPARTICLES AND ARTICLES INCLUDING THE SAME | 3M Innovative Properties Company (US) | 2023-02-15 | — | — | EP | disclosed |
| EP-4127002-A1 | FLUOROPOLYMER COMPRISING PENDENT GROUPS WITH IONIC BIS(SULFONYL)IMIDE MOIETY AND PERFLUOROETHER TERMINAL GROUP | 3M Innovative Properties Company (US) | 2023-02-08 | — | — | EP | disclosed |
| US-5362919-A | Direct fluorination process for making perfluorinated organic substances | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1994-11-08 | — | — | US | disclosed |
| EP-0609200-A1 | DIRECT FLUORINATION PROCESS FOR MAKING PERFLUORINATED ORGANIC SUBSTANCES | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1994-08-10 | — | — | EP | disclosed |
| EP-0557167-A1 | Preparation of fluorinated functional compounds | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1993-08-25 | — | — | EP | disclosed |
| EP-0436669-A1 | PERFLUOROACETAL AND PERFLUOROKETAL COMPOUNDS AND USE THEREOF IN THERMAL SHOCK TESTING | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1991-07-17 | — | — | EP | disclosed |
| EP-0125826-B1 | FLUOROALIPHATIC SULFONAMIDES CONTAINING OXIRANE GROUPS AND/OR N-B-HYDROXYALKYLENE GROUPS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1990-11-14 | — | — | EP | disclosed |
| WO-1990006296-A1 | DIRECT FLUORINATION PROCESS FOR MAKING PERFLUORINATED ORGANIC SUBSTANCES | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1990-06-14 | — | — | WO | disclosed |
| WO-1990003357-A1 | PERFLUOROACETAL AND PERFLUOROKETAL COMPOUNDS AND USE THEREOF IN THERMAL SHOCK TESTING | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1990-04-05 | — | — | WO | disclosed |
| US-4533713-A | WATERPROOFING, OIL-REPELLANT CURED POLYEPOXIDES; PROTECTIVE COATINGS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1985-08-06 | — | — | US | disclosed |
| EP-0125826-A2 | Fluoroaliphatic sulfonamides containing oxirane groups and/or N-B-hydroxyalkylene groups | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1984-11-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170274368-A1 | MULTI-ACID POLYMERS AND METHODS OF MAKING THE SAME | FRS2, FXR2, PFAS | CA2 595/4885CA1 2184/4885MMP1 4866/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.